新闻
2024-03-22
潜在“first-in-class“肿瘤免疫组合疗法2期临床结果积极,支持启动关键性临床试验
疫苗临床结果免疫疗法基因疗法
2024-03-21
Nurix Presents the Discovery and Chemical Structure of First-in-Class CBL-B Inhibitor NX-1607 at the American Chemical Society (ACS) Meeting
临床1期AACR会议
2024-03-21
并购放射疗法
2024-03-21
Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis
孤儿药免疫疗法临床研究细胞疗法快速通道
2024-03-21
Celularity Submits Request to U.S. FDA for Orphan Drug Designation for PDA-002 Asset Treating Facioscapulohumeral Muscular Dystrophy
细胞疗法孤儿药临床研究免疫疗法临床申请
2024-03-21
Sosei Heptares Doses First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease
临床研究
2024-03-21
睿健医药眼科细胞治疗产品获FDA孤儿药资格
孤儿药细胞疗法免疫疗法
2024-03-21
PNAS:科学家揭开开发新型乳腺癌疗法的潜在通路
免疫疗法
2024-03-21
细胞疗法免疫疗法基因疗法信使RNA
2024-03-21
首款!喷一喷显著缓解慢性鼻窦炎,FDA批准创新疗法
基因疗法